Tarsus Pharmaceuticals TARS Insider Ownership

NASDAQ TARS

$71.56 +0.53 (+0.74%)

As of: Oct 21, 2026 · 2:12 PM EDT

Insider Holdings by Owner

5.00Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

3.08%

▼-0.139% pp QoQ

Shares Held by Insiders

1.34Mn

filed for Sep 2026

▼-4.31% QoQ

Shares Outstanding

43.39Mn

43,393,643 shares

Direct Holdings

485.77K

Indirect: 851.67K

Net Shares Traded (QoQ)

-60.20K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 5, 2026

Over the past year, TARS insiders sold $19.96 million of stock (271.56K shares) on the open market and bought none.

Behind Tarsus Pharmaceuticals' open-market sales in the past 12 months were 9 insiders, and no insider bought.
Bobak R. Azamian (President/CEO and Board Chair) was TARS's largest open-market seller in the past 12 months, with $5.18 million of sales (70.6K shares); the latest was on September 4, 2026.
The latest open-market trade in TARS stock by an insider was a sale of 12.5K shares for $979,744 by William J. Link (Director) on September 15, 2026.
Outside the open market, Tarsus Pharmaceuticals insiders acquired 224.72K shares through option exercises and conversions and gave away 52.84K shares as gifts over the past 12 months.
Business Quant data puts insider holdings in TARS at 1.34Mn shares across insiders' latest Form 4 filings, or 3.08% of the 43.39Mn shares outstanding; that total is down 4.31% from 1.4Mn shares at the end of Q2 2026 and down 2.13% from 1.37Mn shares at the end of Q3 2025.
Tarsus Pharmaceuticals insiders hold 485.77K shares directly (36.32% of their total) and 851.67K shares (63.68%) indirectly, through entities such as trusts and partnerships.
Holdings in Tarsus Pharmaceuticals stock are reported by 14 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Tarsus Pharmaceuticals' top three insider holders by shares held are Bobak R. Azamian (President/CEO and Board Chair, 861.41K shares), William J. Link (Director, 94.49K shares) and Seshadri Neervannan (Chief Operating Officer, 79.01K shares).
Bobak R. Azamian alone accounts for 64.41% of the shares held by Tarsus Pharmaceuticals insiders.
In the past year, 14 insiders of Tarsus Pharmaceuticals submitted 59 Form 4 filings reporting trades, awards or other transactions.
These insider figures for Tarsus Pharmaceuticals are based on Form 4 filings through September 17, 2026.

Form 4 Holdings

Insiders Holding TARS

Insiders 20

Shares held 5.00Mn

Of outstanding 11.53%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Capital Ix, Llc Vivo	TenPercentOwner	0	2,469,001	2,469,001	49.3%	05 May, 2022
2	Michael Ackermann	Director	1,208,273	0	1,208,273	24.1%	17 Jun, 2022
3	Bobak R. Azamian	President/Ceo And Board Chair	0	827,991	827,991	16.5%	09 Sep, 2026
4	William J Phd Link	Director	94,487	0	94,487	1.9%	17 Sep, 2026
5	Seshadri Neervannan	Chief Operating Officer	78,532	0	78,532	1.6%	09 Sep, 2026
6	Bryan Wahl	General Counsel	63,959	0	63,959	1.3%	19 Mar, 2026
7	Aziz Mottiwala	Chief Commercial Officer	61,480	0	61,480	1.2%	19 Mar, 2026
8	Jeffrey S Farrow	Officer	56,801	0	56,801	1.1%	17 Jun, 2026
9	Dianne C. Whitfield	Chief Human Resources Officer	35,028	0	35,028	0.7%	19 Mar, 2026
10	Leonard M. Greenstein	Chief Financial Officer	26,785	0	26,785	0.5%	21 Apr, 2023
11	Andrew D. Goldberg	Director	19,654	0	19,654	0.4%	16 Jun, 2026
12	Wendy L Yarno	Director	16,956	0	16,956	0.3%	17 Sep, 2026
13	Bhaskar Chaudhuri	Director	11,654	0	11,654	0.2%	16 Jun, 2026
14	David E I Pyott	Director	0	9,575	9,575	0.2%	17 Sep, 2026
15	Scott W Morrison	Director	7,638	0	7,638	0.2%	16 Jun, 2026
16	Rosemary A Crane	Director	5,350	0	5,350	0.1%	25 Jun, 2024
17	Elizabeth Yeu Lin	Chief Medical Officer	2,547	1,590	4,137	0.1%	09 Sep, 2026
18	Mark J. Holdbrook	V.P., Clinical Affairs	3,191	0	3,191	0.1%	21 Mar, 2023
19	Jose M. Trevejo	Chief Medical Officer	2,251	0	2,251	0.0%	22 Dec, 2023
20	Katherine Goodrich	Director	2,233	0	2,233	0.0%	17 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

684 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
15 Sep, 2026	Wendy L Yarno	Director	Acquired M	302	—	—	16,956	Direct
15 Sep, 2026	William J Phd Link	Director	Acquired M	201	—	—	106,987	Direct
15 Sep, 2026	David E I Pyott	Director	Acquired M	201	—	—	9,575	Indirect
15 Sep, 2026	David E I Pyott	Director	Disposed M	201	$0.00	$0	605	Direct
15 Sep, 2026	Wendy L Yarno	Director	Disposed M	302	$0.00	$0	907	Direct
15 Sep, 2026	William J Phd Link	Director	Disposed S	11,675	$78.33	$914.50K	95,312	Direct
15 Sep, 2026	William J Phd Link	Director	Disposed S	759	$79.00	$59.96K	94,553	Direct
15 Sep, 2026	William J Phd Link	Director	Disposed S	66	$80.01	$5.28K	94,487	Direct
15 Sep, 2026	William J Phd Link	Director	Disposed M	201	$0.00	$0	605	Direct
04 Sep, 2026	Bobak R. Azamian	President/Ceo And Board Chair	Disposed S	7,100	$90.27	$640.92K	830,891	Indirect
04 Sep, 2026	Seshadri Neervannan	Chief Operating Officer	Disposed S	4,564	$85.00	$387.94K	78,532	Direct
04 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	5,387	$85.00	$457.90K	7,933	Direct
04 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	5,386	$90.00	$484.74K	2,547	Direct
04 Sep, 2026	Bobak R. Azamian	President/Ceo And Board Chair	Disposed S	2,900	$91.27	$264.68K	827,991	Indirect
04 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	1,590	$85.00	$135.15K	3,180	Indirect
04 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	1,590	$90.00	$143.10K	1,590	Indirect
01 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	4,601	$73.86	$339.83K	18,707	Direct
02 Sep, 2026	Bobak R. Azamian	President/Ceo And Board Chair	Disposed S	10,000	$80.06	$800.60K	837,991	Indirect
02 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	5,387	$80.00	$430.96K	13,320	Direct
02 Sep, 2026	Elizabeth Yeu Lin	Chief Medical Officer	Disposed S	1,590	$80.00	$127.20K	4,770	Indirect

Showing 1 to 20 of 684 transactions